Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis

Scientists demonstrated that acute treatment with the antiandrogen enzalutamide decreased glutathione production, increased lipid peroxidation, and induced ferroptosis in prostate cancer cells.